1. Home
  2. TWN vs BWAY Comparison

TWN vs BWAY Comparison

Compare TWN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TWN

Taiwan Fund Inc. (The)

N/A

Current Price

$57.14

Market Cap

327.0M

Sector

Finance

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$16.27

Market Cap

337.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWN
BWAY
Founded
1986
2003
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.0M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TWN
BWAY
Price
$57.14
$16.27
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
20.1K
61.3K
Earning Date
01-01-0001
11-11-2025
Dividend Yield
1.10%
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
N/A
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
N/A
$22.24
P/E Ratio
N/A
$53.28
Revenue Growth
N/A
27.08
52 Week Low
$25.22
$7.84
52 Week High
$41.51
$18.18

Technical Indicators

Market Signals
Indicator
TWN
BWAY
Relative Strength Index (RSI) 54.54 46.21
Support Level $56.65 $16.75
Resistance Level $58.67 $17.38
Average True Range (ATR) 1.25 0.75
MACD 0.17 -0.07
Stochastic Oscillator 57.64 21.06

Price Performance

Historical Comparison
TWN
BWAY

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: